⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
UNCY News
Unicycive Therapeutics, Inc. Common Stock
Unicycive Therapeutics Announces Resubmission of New Drug Application for Oxylanthanum Carbonate
globenewswire.com
UNCY
Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. (UNCY) Shareholders of Class Action Lawsuit and November 2, 2026 Deadline
accessnewswire.com
UNCY
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit
prnewswire.com
UNCY
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY
globenewswire.com
UNCY
Form 8-K
sec.gov
UNCY
Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. (UNCY) Investors - Lead Plaintiff Deadline on November 2, 2026
accessnewswire.com
UNCY
UNCY SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Unicycive Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
UNCY
Unicycive Therapeutics, Inc. (UNCY) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before November 2, 2026
accessnewswire.com
UNCY
Bronstein, Gewirtz & Grossman LLC Urges Unicycive Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
UNCY
UNCY Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Unicycive Therapeutics Securities Lawsuit - Contact Levi & Korsinsky
globenewswire.com
UNCY